The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

A federal judge blocked President Donald Trump's effort to slash funding for National Institutes of Health research programs at universities and medical systems that threatened a key source of funding ...

While 22 states have sued the Trump Administration to temporarily block a major policy change by the National Institute of ...

Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.

Various university researchers share their experiences and worries regarding the recent freeze of multiple federal agencies ...

UB's Mickey Sperlich and the Buffalo Prenatal-Perinatal Network will use an NIH award to address the effects of trauma during ...